Compare AdaptHealth Corp (AHCO) vs General Motors Company (GM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs General Motors Company — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while General Motors Company trades at $75.7 (market cap $68.55B). The key difference: General Motors Company is far larger — about 49.7× AdaptHealth Corp's market cap, and General Motors Company pays a 0.95% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | GM | |
|---|---|---|
Market Cap | $1.38B | $68.55B |
Sector | Health | Consumer Cyclical |
52-Week High | $13.38 | $86.38 |
52-Week Low | $8.68 | $48.89 |
Enterprise Value | $3.33B | $171.89B |
Dividend Yield | — | 0.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
General Motors (GM) trades at $76.03, showing minimal daily movement with a 0.04% gain. The stock presents a mixed technical picture with bearish moving averages but oversold RSI conditions. Fundamentally, GM demonstrates strong cash flow generation ($26.9B operating cash flow in 2025) and consistent earnings beats, though profit margins remain thin at 1.38%. Recent news highlights strategic partnerships with Micron Technology and ongoing EV transition challenges.
GM offers value with attractive valuation multiples (P/S: 0.4x, P/B: 1.12x) and analyst consensus pointing to 31% upside potential. However, investors face risks from cyclical auto demand, margin pressure, and high debt levels. The company's scale and cash flow strength provide stability, but execution on EV strategy remains critical for long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →
